<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350954/" ref="ordinalpos=1607&amp;ncbi_uid=4011837&amp;link_uid=PMC3350954" image-link="/pmc/articles/PMC3350954/figure/fig3/" class="imagepopup">Figure 3.  From: Electroacupuncture Pretreatment as a Novel Avenue to Protect Brain against Ischemia and Reperfusion Injury. </a></div><br /><div class="p4l_captionBody">Intracellular signaling pathway of endocannabinoid system in neuroprotection. This graph shows the endocannabinoid system and the post-receptor signaling pathway involved in its neuroprotective effect. (a) signaling pathway of CB1R in neuroprotection; (b) signaling pathway of CB2R in neuroprotection. AEA: N-arach-idonoyl-ethanolamine-anandamide; 2-AG: 2-arachidonylglycerol; CB1R: cannabinoid receptor type 1; PLC: phospholipase c; IP3: inositol triphosphate; ER: endoplasmic reticulum; DAG: diacylglycerol; FAN: factor associated with neutral sphingomyelinase; AC: adenylatecyclase; cAMP: cyclic adenosine monophosphate; PI3K: phosphatidylinositol 3-kinase; MAPK: mitogen-activated protein kinase; ÎµPKC: epsilon protein kinase C; PKA: protein kinase A; AKT: protein kinase B.</div></div>